QT Intervals Study to Compare the Acute Effects of Orally Inhaled Dihydroergotamine (DHE), Oral Moxifloxacin, and Placebo
Clinical trial NCT01191723 · COMPLETED
Trial details
- NCT number
- NCT01191723
- Sponsor
- Allergan
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2010-08-01
- Primary completion
- 2010-09-01
- Enrollment
- 54
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.